Journals / MN Oftalmoloji / 2010 / Cilt: 17 - Sayı: 1

Diagnosis and management of central serous chorioretinopathy in Behcet’s disease

Behçet hastalığı ile birlikte seyreden santral seröz koryoretinopatinin tanınması ve tedavisi

Pages
57–60
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The CSCR regressed and the improvement of Behcet’s findings was achieved by the adjustment of cyclosporine dose and addition of azathioprine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diagnosing central serous chorioretinopathy (CSCR) in the presence of severe retinal findings due to ocular Behcet’s disease may be difficult.
📊
Key Findings & Data:Furthermore, management may prove hardship in such cases since the corticosteroids used in the treatment of Behcet’s disease may further complicate CSCR.
💡
Conclusion & Impact:The CSCR regressed and the improvement of Behcet’s findings was achieved by the adjustment of cyclosporine dose and addition of azathioprine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Erişkin · Santral seröz kardiyoretinopati · Panüveit

Abstract

Diagnosing central serous chorioretinopathy (CSCR) in the presence of severe retinal findings due to ocular Behcet’s disease may be difficult. Furthermore, management may prove hardship in such cases since the corticosteroids used in the treatment of Behcet’s disease may further complicate CSCR. The high dose corticosteroid therapy was rapidly tapered and cyclosporine A was started upon recognition of CSCR findings in a case of ocular Behcet’s disease. The CSCR regressed and the improvement of Behcet’s findings was achieved by the adjustment of cyclosporine dose and addition of azathioprine.

Özet

Oküler Behçet hastalığına bağlı şiddetli retinal bulgular varlığında eşzamanlı santral seröz koryoretinopati (SSKR) tanısını koymak güç olabilir. Dahası, Behçet hastalığının tedavisinde kullanılacak olan kortikosteroidler SSKR’yi kötüleştireceği için her iki durumun aynı anda tedavisi zorluk arzedebilir. Oküler Behçet hastalığı nedeniyle yüksek doz kortikosteroid almakta olan bir hastada SSKR bulguları izlenmesi üzerine kortikosteroid tedavisini hızla kesildi ve siklosporin A başlandı. Bu şekilde SSKR düzelirken, Behçet hastalığına ait göz bulgularında siklosporin dozundaki ayarlama ve azathioprin ilavesi ile belirgin düzelme izlendi.

🔖

Cite This Article

ÇETİNKAYA, A., AKOVA, Y. A., YILMAZ, G., AYGEN, A. (2010). Diagnosis and management of central serous chorioretinopathy in Behcet’s disease. MN Oftalmoloji, Cilt: 17 - Sayı: 1, 57–60. https://ajindex.com/articles/295794

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1984; 68: 329-31
  2. Carvalho-Recchia CA, Yannuzzi LA, Negrão S, ve ark. Corticosteroids and central serous chorioretinopathy. Ophthalmology 2002; 109:1834-7
  3. Stoffelns BM, Kramann C, Schoepfer K. Central serous chorioretinopathy (CSC) and corticosteroids. Klin Monbl Augenheilkd 2008; 225:370-5
  4. Pizzimenti JJ, Daniel KP. Central serous chorioretinopathy after epidural steroid injection. Pharmacotherapy 2005; 25:1141-6
  5. Yilmaz G, Akova YA, Aydin P. Macular ischemia in Behcet’s disease. Eye 2000; 14:717-20
  6. Gedik S, Akova Y, Yilmaz G, Bozbeyoglu S. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease. Ocull Immunol Inflamm 2005; 13:51-8
  7. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Central serous chorioretinopathy case-control study group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004; 111:244-9
  8. Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol 2004; 242:800-2
  9. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 1997; 41:180-5.